Murray, M., Antela, A., Mills, A., Huang, J., Jäger, H., Bernal, E., . . . Chounta, V. (2020). Patient-Reported Outcomes in ATLAS and FLAIR Participants on Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks. AIDS Behav.
シカゴスタイル引用形Murray, Miranda, et al. "Patient-Reported Outcomes in ATLAS and FLAIR Participants On Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks." AIDS Behav 2020.
MLA引用形式Murray, Miranda, et al. "Patient-Reported Outcomes in ATLAS and FLAIR Participants On Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks." AIDS Behav 2020.
警告: この引用は必ずしも正確ではありません.